about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen OsteoPSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts.Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.The use of glucocorticoids in rheumatoid arthritis--no 'rational' approach yetHow B cells influence bone biology in health and diseaseBiomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells.Using hand bone mass measurements to assess progression of rheumatoid arthritis.Establishment and characterization of a sustained delayed-type hypersensitivity model with arthritic manifestations in C57BL/6J mice.HIV and its effects on bone: a primer for rheumatologistsTemporal differential effects of proinflammatory cytokines on osteoclastogenesisChondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis.Protective effect of curcumin on experimentally induced arthritic rats: detailed histopathological study of the joints and white blood cell count.The clinical utility of bone marker measurements in osteoporosis.Inhibitory Effect of Chrysanthemum zawadskii Herbich var. latilobum Kitamura Extract on RANKL-Induced Osteoclast Differentiation.Critical role for inflammasome-independent IL-1β production in osteomyelitis.Osteoimmunology and Beyond.Bone loss in rheumatoid arthritis: systemic, periarticular, and focal.Advances in osteoimmunology: pathophysiologic concepts and treatment opportunities.How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.T Regulatory Cells in Bone Remodelling.Destructive dural ectasia of dorsal and lumbar spine with cauda equina syndrome in a patient with ankylosing spondylitis.Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in miceDecreased quantity and quality of the periarticular and nonperiarticular bone in patients with rheumatoid arthritis: a cross-sectional HR-pQCT study.Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.Bacterial modulators of bone remodeling in the periodontal pocket.Elevated marrow inflammatory cells and osteoclasts in subchondral osteosclerosis in human knee osteoarthritis.
P2860
Q27687777-9E586CB3-B828-41D1-BEF0-BEF70B686C04Q28603734-309642ED-8C8E-4CBC-AE7E-159B0E745A3BQ30525659-C613E23E-08B7-4BD2-BD3B-794D054C8E19Q33805455-94BD800A-011B-4A16-8101-E4C1D1163D35Q34027540-431A40F2-5E22-41B4-B7FD-C84B6DFB0BABQ34137037-7BE52769-A034-45B8-AC7D-6E8730377083Q34425497-7DF8E57E-BBC7-4933-B84C-99970E7A3F6FQ35055978-8F72C78C-E44F-41BF-84FC-7C6E2978592BQ35864012-D08C281F-01A2-4E3B-A950-AC42AD7A5EFAQ36059378-E555C54A-95B0-4566-9FDD-C0579E673545Q36246082-B43348D2-5078-45D8-BBC9-A3857E82A17DQ36381079-7794DF81-902F-4228-B000-7015963AF8C4Q36753683-B203DD82-CE49-4559-9E53-11E3C6B8CE8AQ37011002-19EB50EA-881F-4102-961E-23A3F114C0BDQ37054188-F312B136-BC0F-4F07-A5DF-DB3B8BFBE0FCQ37153332-0FD740D6-5207-4009-8D96-4BFED3C1A2CDQ37224788-1005B6E6-4697-4257-9832-FF99453E8C5FQ37519575-8CA39512-8010-4099-860D-E807C3E04725Q37548012-459E87DF-5232-4E4E-B03F-3CFEA7EE82D8Q38004957-09EFBCCB-9B4B-406E-A995-E631F15C13C5Q38047183-AC49F7AC-7811-42F4-8C58-576C22DD7366Q38120525-1C5FBB51-4F21-429D-B089-572E9814343DQ38218977-DB7C9EFB-DDE4-447D-9571-9236C64D9B8EQ39127801-FF37C79C-C25A-451B-9D67-2102F0F3030DQ39255811-CF0758D1-03EC-4842-AA38-F2292B8385CBQ42044196-DE492AF6-4A9D-409A-AE7A-4F3C40894EF6Q42077222-B8EA65FD-534A-4593-A551-EFEFD48918E9Q44303831-E0AF9EDA-71C9-44C1-BFFB-9CFB538618D4Q48109354-8C7351C4-61B5-4667-AA2F-C204BCB8B1A9Q49380410-FCA35DF4-5E76-4C8F-A065-0306D814919CQ51818684-EF562B60-3947-4EA9-BEB8-7FBE150FDB18
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Osteoimmunology in rheumatic diseases
@en
Osteoimmunology in rheumatic diseases.
@nl
type
label
Osteoimmunology in rheumatic diseases
@en
Osteoimmunology in rheumatic diseases.
@nl
prefLabel
Osteoimmunology in rheumatic diseases
@en
Osteoimmunology in rheumatic diseases.
@nl
P2860
P921
P356
P1476
Osteoimmunology in rheumatic diseases
@en
P2860
P2888
P356
10.1186/AR2571
P50
P577
2009-01-30T00:00:00Z
P5875
P6179
1002142420